EIF5A2 Monoklonaler Antikörper
EIF5A2 Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Ratte
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1F9B2
Kat-Nr. : 67907-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67907-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA EIF5A2 und zeigt Reaktivität mit human, Ratten
Getestete Reaktivität | human, Ratte |
Wirt / Isotyp | Maus / IgG1 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | EIF5A2 fusion protein Ag10852 |
Vollständiger Name | eukaryotic translation initiation factor 5A2 |
Berechnetes Molekulargewicht | 153 aa, 17 kDa |
Beobachtetes Molekulargewicht | 20 kDa |
GenBank-Zugangsnummer | BC036072 |
Gene symbol | EIF5A2 |
Gene ID (NCBI) | 56648 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-G-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Eukaryotic translation initiation factor 5A (EIF5A), a conserved lysine to hypusine, is strictly indispensable for the survival of eukaryotic cells. There are two EIF5A isoforms in humans: EIF5A1 and EIF5A2. EIF5A2 has been reported to be overexpressed in gallbladder cancer, upper urinary tract urothelial carcinoma, gastric cancer, prostate cancer, nasopharyngeal carcinoma, and cervical cancer. EIF5A2 upregulation in cancer tissues is associated with poor prognosis in these patients.